Holder evidence
0
SEC ownership of ACCELERON PHARMA INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001280600.
Lead holder
—
13D/G signal
—
Latest evidence
—
- CIK
- 0001280600
- Location
- Cambridge, MA
- SEC evidence mix
- 13F, 13D/G, and Forms 3/4/5
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of ACCELERON PHARMA INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
—
13D/G signal
—
Evidence rows
0
Latest as of
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 31 May 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to ACCELERON PHARMA INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Lead holder
Sujay Kango
Net 12M change
$0
Latest report
19 Nov 2021
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Sujay Kango | EVP, Chief Commercial Officer | Mixed | 19 Nov 2021 | |||
| Backstrom Jay T. | EVP, Research and Development | Mixed | 19 Nov 2021 | |||
| Terrence C. Kearney | Director | Mixed | 19 Nov 2021 | |||
| Christopher Hite | Director | Mixed | 19 Nov 2021 | |||
| Joseph S. Zakrzewski | Director | Mixed | 19 Nov 2021 | |||
| Adam M. Veness | SVP, General Counsel and Sec. | Mixed | 19 Nov 2021 | |||
| Thomas A. Mccourt | Director | Mixed | 19 Nov 2021 | |||
| Kemal Malik | Director | Mixed | 19 Nov 2021 | |||
| Kevin F. McLaughlin | SVP, CFO and Treasurer | Mixed | 19 Nov 2021 | |||
| Karen L. Smith | Director | Mixed | 19 Nov 2021 | |||
| Francois Nader | Director | Mixed | 19 Nov 2021 | |||
| Laura Hamill | Director | Mixed | 19 Nov 2021 | |||
| Habib J. Dable | CEO and President, Director | Mixed | 19 Nov 2021 |
Recent insider transactions for ACCELERON PHARMA INC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* indicates a reported price that failed the local validity check.